Lysogene Reports First Half 2020 Financial Results and Provides Operational Update
https://www.lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg
150
150
Lysogene
https://www.lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg
Cash position of €23.8m as of 30 June 2020 strengthened by a €7.7m capital increase ledby OrbiMed and Sarepta, extending cash runway to Q4 2021